Almirall

Almirall is a leading Medical Dermatology pharmaceutical company dedicated to apply Science to improve the health of patients worldwide by fighting against skin diseases.
Our External Research & Innovation team are actively searching new in-licensing assets and/or research programs at any stage of development:
– Autoimmune disorders: AD, Pruritus, Psoriasis, Vitiligo, Alopecia Aerata, …
– Orphan diseases: EB, Hidradenitis suppurativa, Pemphigus, Bullous pemphigoid, CTCL, …
– Onco Dermatology diseases: BCC, SCC, AK, …
– Infection/inflammation diseases : Acne, rosacea, warts, onychomycosis, …

The company is listed on the Spanish Stock Exchange (ALM). For more information, please visit:

https://www.almirall.com